Chronic Kidney Disease

Ascend, a dialysis testing laboratory, announced the start of a strategic relationship with the medical technology company Siemens Healthineers.

Nearly 20 members of Congress signed a letter urging President Joe Biden to allocate $25 million for KidneyX in the executive budget for the 2023 fiscal year.

A meta-analysis revealed no significant difference in primary study outcomes using Ellipsys or WavelinQ to create arteriovenous fistulas in patients requiring access for dialysis.

Researchers found it feasible for patients with incident kidney dysfunction requiring dialysis to receive incremental-start hemodialysis with adjuvant pharmacotherapy.

Dietitians who provide nutrition care to kidney patients are limited around the globe and availability varies in countries, according to data published in Clinical Journal of the American Society of Nephrology.

Findings published in the Journal of Renal Nutrition demonstrated the appropriate prescribing method of oral nutrition supplements to patients with non-dialysis chronic kidney disease.

According to a research letter published in Kidney Medicine, kidney function decline correlated with higher nocturnal blood pressure among patients with chronic kidney disease.

In a cohort of patients with MI and mild or moderate chronic kidney disease, Black individuals were less likely to receive invasive management compared with their white counterparts, researchers reported.

At least one in three patients who survived AKI and required hemodialysis recovered kidney function within the first 90 days after discharge from the hospital, according to recently published data.

Cara Therapeutics Inc. announced that Korsuva injection received CMS transitional drug add-on payment adjustment in the anti-pruritic functional category.